國立虎尾科技大學 |

NAFLD and NASH = Biomarkers in Detection, Diagnosis and Monitoring /

Record Type:	Language materials, printed : Monograph/item
Title/Author:	NAFLD and NASH/ edited by Manuel Romero-Gomez.
Reminder of title:	Biomarkers in Detection, Diagnosis and Monitoring /
other author:	Romero-Gomez, Manuel.
Description:	X, 236 p. 18 illus., 17 illus. in color.online resource. :
Contained By:	Springer Nature eBook
Subject:	Hepatology. -
Online resource:	https://doi.org/10.1007/978-3-030-37173-9
ISBN:	9783030371739

NAFLD and NASH = Biomarkers in Detection, Diagnosis and Monitoring /
NAFLD and NASHBiomarkers in Detection, Diagnosis and Monitoring /[electronic resource] :edited by Manuel Romero-Gomez. - 1st ed. 2020. - X, 236 p. 18 illus., 17 illus. in color.online resource.

Foreword -- Biochemical biomarkers of NAFLD/NASH -- MR based-Imaging Biomarkers in NAFLD/NASH -- Detection of NAFLD/NASH in general population -- Micro-vesicles in the diagnosis and monitoring of NASH -- Non-invasive biomarkers for monitoring NASH: NASH resolution and Fibrosis regression -- From transcriptome to proteomic in the development of biomarkers in NAFLD/NASH -- Transient elastography and ultrasound as imaging biomarkers in NAFLD/NASH -- Early detection of HCC in patients with NAFLD/NASH -- Genes and NAFLD/NASH progression -- Geometry of nutrition: micronutrients and NAFLD progression -- Psychological biomarkers profile in NAFLD/NASH with advanced fibrosis -- Integrative proposal of biomarkers use in clinical practice management of NAFLD/NASH.

This book provides a comprehensive overview of the diagnosis and management of Non-alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatis (NASH). Basic principles of disease progression, the genetic and nutritional basis of NAFLD and NASH are explained along with the proteomic principles underlying biomarker development. Chapters cover both biochemical and imaging biomarkers used in elastrography and ultrasound and discuss how these are applicable to early diagnosis and monitoring of NASH and NAFLD. This is a useful resource for hepatologists, primary care providers with an interest in metabolic disease, diabetologists and endocrinologists in their daily clinical practice.

ISBN: 9783030371739

Standard No.: 10.1007/978-3-030-37173-9doiSubjects--Topical Terms:

673859
Hepatology.

LC Class. No.: RC841-858.P35

Dewey Class. No.: 616.36

NAFLD and NASH = Biomarkers in Detection, Diagnosis and Monitoring /
LDR:02811nam a22003975i 4500 001 1026732
003 DE-He213
005 20200702042916.0
007 cr nn 008mamaa
008 210318s2020 gw | s |||| 0|eng d
020 $a 9783030371739 $9 978-3-030-37173-9
024 7 $a 10.1007/978-3-030-37173-9 $2 doi
035 $a 978-3-030-37173-9
050 4 $a RC841-858.P35
072 7 $a MJJ $2 bicssc
072 7 $a MED031000 $2 bisacsh
072 7 $a MJJ $2 thema
082 0 4 $a 616.36 $2 23
245 1 0 $a NAFLD and NASH $h [electronic resource] : $b Biomarkers in Detection, Diagnosis and Monitoring / $c edited by Manuel Romero-Gomez.
250 $a 1st ed. 2020.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2020.
300 $a X, 236 p. 18 illus., 17 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
505 0 $a Foreword -- Biochemical biomarkers of NAFLD/NASH -- MR based-Imaging Biomarkers in NAFLD/NASH -- Detection of NAFLD/NASH in general population -- Micro-vesicles in the diagnosis and monitoring of NASH -- Non-invasive biomarkers for monitoring NASH: NASH resolution and Fibrosis regression -- From transcriptome to proteomic in the development of biomarkers in NAFLD/NASH -- Transient elastography and ultrasound as imaging biomarkers in NAFLD/NASH -- Early detection of HCC in patients with NAFLD/NASH -- Genes and NAFLD/NASH progression -- Geometry of nutrition: micronutrients and NAFLD progression -- Psychological biomarkers profile in NAFLD/NASH with advanced fibrosis -- Integrative proposal of biomarkers use in clinical practice management of NAFLD/NASH.
520 $a This book provides a comprehensive overview of the diagnosis and management of Non-alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatis (NASH). Basic principles of disease progression, the genetic and nutritional basis of NAFLD and NASH are explained along with the proteomic principles underlying biomarker development. Chapters cover both biochemical and imaging biomarkers used in elastrography and ultrasound and discuss how these are applicable to early diagnosis and monitoring of NASH and NAFLD. This is a useful resource for hepatologists, primary care providers with an interest in metabolic disease, diabetologists and endocrinologists in their daily clinical practice.
650 0 $a Hepatology. $3 673859
650 0 $a Endocrinology . $3 1254221
650 0 $a Metabolism. $3 581368
650 2 4 $a Endocrinology. $3 645497
650 2 4 $a Metabolomics. $3 882386
700 1 $a Romero-Gomez, Manuel. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1323062
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783030371722
776 0 8 $i Printed edition: $z 9783030371746
776 0 8 $i Printed edition: $z 9783030371753
856 4 0 $u https://doi.org/10.1007/978-3-030-37173-9
912 $a ZDB-2-SME
912 $a ZDB-2-SXM
950 $a Medicine (SpringerNature-11650)
950 $a Medicine (R0) (SpringerNature-43714)